- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2049-3002
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
SGLT2 inhibition slows tumor growth in mice by reversing hyperinsulinemia ; volume:7 ; number:1 ; day:11 ; month:12 ; year:2019 ; pages:1-13 ; date:12.2019
Cancer & metabolism ; 7, Heft 1 (11.12.2019), 1-13, 12.2019
- Creator
-
Nasiri, Ali R.
Rodrigues, Marcos R.
Li, Zongyu
Leitner, Brooks P.
Perry, Rachel J.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s40170-019-0203-1
- URN
-
urn:nbn:de:101:1-2020040512484890747807
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:45 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Nasiri, Ali R.
- Rodrigues, Marcos R.
- Li, Zongyu
- Leitner, Brooks P.
- Perry, Rachel J.
- SpringerLink (Online service)
Other Objects (12)
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Reversing Fields
Reversing Emissions
Reversing Emancipation?
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Reversing the proverb
Reversing Event Structures
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Reversing Fields
Reversing Emissions
Reversing Emancipation?
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Reversing the proverb
Reversing Event Structures
SGLT2-inhibition in patients with Alport syndrome
SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
SGLT2 inhibition with empagliflozin improves coronary microvascular function and cardiac contractility in prediabetic ob/ob−/− mice
Reversing Fields
Reversing Emissions
Reversing Emancipation?
SGLT2 inhibition eliminates senescent cells and alleviates pathological aging
SGK1 inhibition-induced autophagy impairs prostate cancer metastasis by reversing EMT
SGLT2 inhibition and adipose tissue metabolism: current outlook and perspectives
SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice
Reversing the proverb